Literature DB >> 24272953

A novel frameshift mutation in the AFG3L2 gene in a patient with spinocerebellar ataxia.

Zuzana Musova1, Michaela Kaiserova, Eva Kriegova, Regina Fillerova, Peter Vasovcak, Alena Santava, Katerina Mensikova, Alena Zumrova, Anna Krepelova, Zdenek Sedlacek, Petr Kanovsky.   

Abstract

Spinocerebellar ataxia type 28 (SCA28) is an autosomal dominant neurodegenerative disorder caused by missense AFG3L2 mutations. To examine the occurrence of SCA28 in the Czech Republic, we screened 288 unrelated ataxic patients with hereditary (N = 49) and sporadic or unknown (N = 239) form of ataxia for mutations in exons 15 and 16, the AFG3L2 mutation hotspots. A single significant variant, frameshift mutation c.1958dupT leading to a premature termination codon, was identified in a patient with slowly progressive speech and gait problems starting at the age of 68 years. Neurological examination showed cerebellar ataxia, mild Parkinsonian features with predominant bradykinesia, polyneuropathy of the lower limbs, and cognitive decline. However, other common SCA28 features like pyramidal tract signs (lower limb hyperreflexia, positive Babinski sign), ophthalmoparesis or ptosis were absent. The mutation was also found in a patient's unaffected daughter in whom a targeted examination at 53 years of age revealed mild imbalance signs. RNA analysis showed a decreased ratio of the transcript from the mutated AFG3L2 allele relative to the normal transcript in the peripheral lymphocytes of both patients. The ratio was increased by puromycin treatment, indicating that the mutated transcript can be degraded via nonsense-mediated RNA decay. The causal link between the mutation and the phenotype of the patient is currently unclear but a pathogenic mechanism based on AFG3L2 haploinsufficiency rather than the usual dominant-negative effect of missense AFG3L2 mutations reported in SCA28, cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24272953     DOI: 10.1007/s12311-013-0538-z

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  24 in total

Review 1.  Quality control of mitochondria: protection against neurodegeneration and ageing.

Authors:  Takashi Tatsuta; Thomas Langer
Journal:  EMBO J       Date:  2008-01-23       Impact factor: 11.598

2.  Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.

Authors:  Stephan Klebe; Christel Depienne; Sylvie Gerber; Georges Challe; Mathieu Anheim; Perrine Charles; Estelle Fedirko; Elodie Lejeune; Julien Cottineau; Alfredo Brusco; Hélène Dollfus; Patrick F Chinnery; Cecilia Mancini; Xavier Ferrer; Guilhem Sole; Alain Destée; Jean-Michel Mayer; Bertrand Fontaine; Jérôme de Seze; Michel Clanet; Elisabeth Ollagnon; Philippe Busson; Cécile Cazeneuve; Giovanni Stevanin; Josseline Kaplan; Jean-Michel Rozet; Alexis Brice; Alexandra Durr
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

Review 3.  NMD: a multifaceted response to premature translational termination.

Authors:  Stephanie Kervestin; Allan Jacobson
Journal:  Nat Rev Mol Cell Biol       Date:  2012-10-17       Impact factor: 94.444

4.  Haploinsufficiency of AFG3L2, the gene responsible for spinocerebellar ataxia type 28, causes mitochondria-mediated Purkinje cell dark degeneration.

Authors:  Francesca Maltecca; Raffaella Magnoni; Federica Cerri; Gregory A Cox; Angelo Quattrini; Giorgio Casari
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

5.  Spinocerebellar ataxia type 28: a novel autosomal dominant cerebellar ataxia characterized by slow progression and ophthalmoparesis.

Authors:  Caterina Mariotti; Alfredo Brusco; Daniela Di Bella; Claudia Cagnoli; Marco Seri; Cinzia Gellera; Stefano Di Donato; Franco Taroni
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

6.  Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19.

Authors:  Anna Duarri; Justyna Jezierska; Michiel Fokkens; Michel Meijer; Helenius J Schelhaas; Wilfred F A den Dunnen; Freerk van Dijk; Corien Verschuuren-Bemelmans; Gerard Hageman; Pieter van de Vlies; Benno Küsters; Bart P van de Warrenburg; Berry Kremer; Cisca Wijmenga; Richard J Sinke; Morris A Swertz; Harm H Kampinga; Erik Boddeke; Dineke S Verbeek
Journal:  Ann Neurol       Date:  2012-12       Impact factor: 10.422

7.  A highly annotated whole-genome sequence of a Korean individual.

Authors:  Jong-Il Kim; Young Seok Ju; Hansoo Park; Sheehyun Kim; Seonwook Lee; Jae-Hyuk Yi; Joann Mudge; Neil A Miller; Dongwan Hong; Callum J Bell; Hye-Sun Kim; In-Soon Chung; Woo-Chung Lee; Ji-Sun Lee; Seung-Hyun Seo; Ji-Young Yun; Hyun Nyun Woo; Heewook Lee; Dongwhan Suh; Seungbok Lee; Hyun-Jin Kim; Maryam Yavartanoo; Minhye Kwak; Ying Zheng; Mi Kyeong Lee; Hyunjun Park; Jeong Yeon Kim; Omer Gokcumen; Ryan E Mills; Alexander Wait Zaranek; Joseph Thakuria; Xiaodi Wu; Ryan W Kim; Jim J Huntley; Shujun Luo; Gary P Schroth; Thomas D Wu; HyeRan Kim; Kap-Seok Yang; Woong-Yang Park; Hyungtae Kim; George M Church; Charles Lee; Stephen F Kingsmore; Jeong-Sun Seo
Journal:  Nature       Date:  2009-07-08       Impact factor: 49.962

8.  Variable and tissue-specific subunit composition of mitochondrial m-AAA protease complexes linked to hereditary spastic paraplegia.

Authors:  Mirko Koppen; Metodi D Metodiev; Giorgio Casari; Elena I Rugarli; Thomas Langer
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

9.  The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria.

Authors:  Mark Nolden; Sarah Ehses; Mirko Koppen; Andrea Bernacchia; Elena I Rugarli; Thomas Langer
Journal:  Cell       Date:  2005-10-21       Impact factor: 41.582

10.  Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease.

Authors:  G Casari; M De Fusco; S Ciarmatori; M Zeviani; M Mora; P Fernandez; G De Michele; A Filla; S Cocozza; R Marconi; A Dürr; B Fontaine; A Ballabio
Journal:  Cell       Date:  1998-06-12       Impact factor: 41.582

View more
  9 in total

1.  Non-syndromic isolated dominant optic atrophy caused by the p.R468C mutation in the AFG3 like matrix AAA peptidase subunit 2 gene.

Authors:  Davide Colavito; Veronica Maritan; Agnese Suppiej; Elda Del Giudice; Monica Mazzarolo; Stefania Miotto; Sofia Farina; Maurizio Dalle Carbonare; Stefano Piermarocchi; Alberta Leon
Journal:  Biomed Rep       Date:  2017-09-22

Review 2.  Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing.

Authors:  Marie Coutelier; Giovanni Stevanin; Alexis Brice
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

3.  Neurocognitive Characterization of an SCA28 Family Caused by a Novel AFG3L2 Gene Mutation.

Authors:  Laszlo Szpisjak; Viola L Nemeth; Noemi Szepfalusi; Denes Zadori; Zoltan Maroti; Tibor Kalmar; Laszlo Vecsei; Peter Klivenyi
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

Review 4.  Mitochondrial Quality Control Proteases in Neuronal Welfare.

Authors:  Roman M Levytskyy; Edward M Germany; Oleh Khalimonchuk
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-02       Impact factor: 4.147

5.  Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activation.

Authors:  Susanna Tulli; Andrea Del Bondio; Valentina Baderna; Davide Mazza; Franca Codazzi; Tyler Mark Pierson; Alessandro Ambrosi; Dagmar Nolte; Cyril Goizet; Camilo Toro; Jonathan Baets; Tine Deconinck; Peter DeJonghe; Paola Mandich; Giorgio Casari; Francesca Maltecca
Journal:  J Med Genet       Date:  2019-03-25       Impact factor: 6.318

Review 6.  Spinocerebellar ataxia type 28 in a Chinese pedigree: A case report and literature review.

Authors:  Xiaoyang Liu; Linlin Wang; Jiajun Chen; Chunyang Kang; Jia Li
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

7.  A novel mutation of AFG3L2 might cause dominant optic atrophy in patients with mild intellectual disability.

Authors:  Majida Charif; Agathe Roubertie; Sara Salime; Sonia Mamouni; Cyril Goizet; Christian P Hamel; Guy Lenaers
Journal:  Front Genet       Date:  2015-10-19       Impact factor: 4.599

Review 8.  Cerebellar ataxias: β-III spectrin's interactions suggest common pathogenic pathways.

Authors:  Emma Perkins; Daumante Suminaite; Mandy Jackson
Journal:  J Physiol       Date:  2016-04-24       Impact factor: 5.182

9.  Analysis of 31-year-old patient with SYNGAP1 gene defect points to importance of variants in broader splice regions and reveals developmental trajectory of SYNGAP1-associated phenotype: case report.

Authors:  Darina Prchalova; Marketa Havlovicova; Katalin Sterbova; Viktor Stranecky; Miroslava Hancarova; Zdenek Sedlacek
Journal:  BMC Med Genet       Date:  2017-06-02       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.